Interest Expense in USD of Atara Biotherapeutics, Inc. from Q1 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Interest Expense history and change rate from Q1 2022 to Q3 2025.
  • Atara Biotherapeutics, Inc. Interest Expense for the quarter ending September 30, 2025 was $909K, a 23.2% decline year-over-year.
  • Atara Biotherapeutics, Inc. Interest Expense for the twelve months ending September 30, 2025 was $3.92M, a 18% decline year-over-year.
  • Atara Biotherapeutics, Inc. annual Interest Expense for 2024 was $4.62M, a 12.7% decline from 2023.
  • Atara Biotherapeutics, Inc. annual Interest Expense for 2023 was $5.29M, a 1317% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Atara Biotherapeutics, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $3.92M $909K -$274K -23.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $4.19M $972K -$290K -23% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $4.48M $1.02M -$136K -11.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $4.62M $1.02M -$159K -13.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-07
Q3 2024 $4.77M $1.18M -$212K -15.2% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 $4.99M $1.26M -$116K -8.42% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 $5.1M $1.15M -$183K -13.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2023 $5.29M $1.18M +$1.06M +905% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-07
Q3 2023 $4.23M $1.4M +$1.27M +1034% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $2.95M $1.38M +$1.25M +968% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $1.71M $1.34M +$1.33M +33300% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $373K $117K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $123K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $129K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $4K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08

Atara Biotherapeutics, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.62M -$670K -12.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-07
2023 $5.29M +$4.91M +1317% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-07
2022 $373K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.